Anbio Biotechnology (NNNN) stock
NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.60−0.05 (-1.37%)
Close on Nov 18, 2026Market cap $518.01MP/E 24.5Yield –
Anbio Biotechnology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Anbio Biotechnology's enterprise value was $164.97M on Nov 11, 2026, against $979.12M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $164.97M | -86.9% |
| 2025 | Dec 31, 2025 | $1.26B | – |
See a number that looks wrong?